Comparison of the efficacy and cost-effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients.

Subjects

Subjects :

Alabama
Antigens, Viral blood
Cost-Benefit Analysis
Critical Care economics
Cytomegalovirus Infections economics
Humans
Postoperative Complications prevention & control
Risk Factors
Antiviral Agents therapeutic use
Cytomegalovirus Infections prevention & control
Ganciclovir therapeutic use
Lung Transplantation

Details

Language :

English

ISSN :

1053-2498

Volume :

19

Issue :

8

Database :

MEDLINE

Journal :

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Publication Type :

Editorial & Opinion

Accession number :

10967278

Full Text :

https://doi.org/10.1016/s1053-2498(00)00143-1